$RSLS
ReShape Lifesciences Inc. Stock $rsls

$rsls Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000155837023006079 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022 Q2
Revenue	$2.254M	$3.110M	$2.892M
YoY Change	-22.06%	-1.02%	-18.05%
Cost Of Revenue	$1.060M	$1.510M	$1.009M
YoY Change	5.05%	10.54%	-26.67%
Gross Profit	$1.194M	$1.600M	$1.883M
YoY Change	-36.59%	-9.91%	-12.54%
Gross Profit Margin	52.97%	51.45%	65.11%
Selling, General & Admin	$2.177M	$5.865M	$4.663M
YoY Change	-53.31%	-29.37%	223.59%
% of Gross Profit	182.33%	366.56%	247.64%
Research & Development	$581.0K	$441.0K	$761.0K
YoY Change	-23.65%	59.21%	638.83%
% of Gross Profit	48.66%	27.56%	40.41%
Depreciation & Amortization	$49.00K	$515.0K	$545.0K
YoY Change	-91.01%	-7.21%	21.11%
% of Gross Profit	4.1%	32.19%	28.94%
Operating Expenses	$5.170M	$6.306M	$11.26M
YoY Change	-54.08%	-26.51%	92.3%
Operating Profit	-$3.976M	-$4.706M	-$9.376M
YoY Change	-57.59%	-30.84%	153.27%
Interest Expense	$9.000K	$166.0K	$14.00K
YoY Change	-35.71%	-653.33%	-108.14%
% of Operating Profit
Other Income/Expense, Net	$6.000K	$2.000K	-$1.000K
YoY Change	-700.0%
Pretax Income	-$3.489M	-$16.48M	-$9.567M
YoY Change	-63.53%	-53.69%	146.95%
Income Tax	$4.000K	$131.0K	$9.000K
% Of Pretax Income
Net Earnings	-$3.493M	-$16.61M	-$9.576M
YoY Change	-63.52%	-53.15%	145.41%
Net Earnings / Revenue	-154.97%	-534.15%	-331.12%
Basic Earnings Per Share	-$1.08		-$0.50
Diluted Earnings Per Share	-$1.08	-$34.02	-$0.50
COMMON SHARES
Basic Shares Outstanding	2.649M	24.18M	19.31M
Diluted Shares Outstanding	3.249M		19.31M

Balance Sheet

Concept	2023 Q2	2022 Q4	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.567M	$3.855M	$11.49M
YoY Change	-60.27%	-83.07%	-71.38%
Cash & Equivalents	$4.567M	$3.855M	$11.49M
Short-Term Investments
Other Short-Term Assets	$112.0K	$84.00K	$197.0K
YoY Change	-43.15%	-55.32%	-23.35%
Inventory	$3.268M	$3.611M	$4.226M
Prepaid Expenses
Receivables	$1.975M	$2.180M	$2.448M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.54M	$9.911M	$19.49M
YoY Change	-45.89%	-67.24%	-70.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$659.0K	$698.0K	$887.0K
YoY Change	-25.7%	-51.99%	-44.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$57.00K	$46.00K	$1.298M
YoY Change	-95.61%	-96.84%	-20.27%
Total Long-Term Assets	$1.308M	$1.231M	$22.44M
YoY Change	-94.17%	-94.87%	-58.75%
TOTAL ASSETS
Total Short-Term Assets	$10.54M	$9.911M	$19.49M
Total Long-Term Assets	$1.308M	$1.231M	$22.44M
Total Assets	$11.85M	$11.14M	$41.93M
YoY Change	-71.73%	-79.46%	-65.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.601M	$1.926M	$2.513M
YoY Change	-36.29%	-44.46%	-18.8%
Accrued Expenses	$2.527M	$5.040M	$5.814M
YoY Change	-56.54%	59.04%	-89.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.404M	$7.481M	$9.190M
YoY Change	-52.08%	2.05%	-84.81%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$710.0K	$0.00	$5.000K
YoY Change	14100.0%	-100.0%	-86.84%
Total Long-Term Liabilities	$710.0K	$0.00	$5.000K
YoY Change	14100.0%	-100.0%	-86.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.404M	$7.481M	$9.190M
Total Long-Term Liabilities	$710.0K	$0.00	$5.000K
Total Liabilities	$5.114M	$7.481M	$9.562M
YoY Change	-46.52%	-8.61%	-84.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$630.3M	-$624.2M	-$594.6M
YoY Change	6.02%	8.23%	13.55%
Common Stock	$3.000K	$1.000K	$20.00K
YoY Change	-85.0%	-94.44%	150.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.738M	$3.661M	$32.36M
YoY Change
Total Liabilities & Shareholders Equity	$11.85M	$11.14M	$41.93M
YoY Change	-71.73%	-79.46%	-65.06%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022 Q2
OPERATING ACTIVITIES
Net Income	-$3.493M	-$16.61M	-$9.576M
YoY Change	-63.52%	-53.15%	145.41%
Depreciation, Depletion And Amortization	$49.00K	$515.0K	$545.0K
YoY Change	-91.01%	-7.21%	21.11%
Cash From Operating Activities	-$6.662M	-$2.830M	-$6.422M
YoY Change	3.74%	-17.4%	193.51%
INVESTING ACTIVITIES
Capital Expenditures	$36.00K	$79.00K	-$12.00K
YoY Change	-400.0%	-217.91%	-84.42%
Acquisitions
YoY Change
Other Investing Activities	$33.00K	$0.00	$30.00K
YoY Change	10.0%	-100.0%	-99.42%
Cash From Investing Activities	-$3.000K	-$79.00K	$18.00K
YoY Change	-116.67%	-97.42%	-99.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.250M	638.0K	2.489M
YoY Change	-9.6%		-92.96%
NET CHANGE
Cash From Operating Activities	-6.662M	-2.830M	-6.422M
Cash From Investing Activities	-3.000K	-79.00K	18.00K
Cash From Financing Activities	2.250M	638.0K	2.489M
Net Change In Cash	-4.415M	-2.271M	-3.915M
YoY Change	12.77%	-65.02%	-110.23%
FREE CASH FLOW
Cash From Operating Activities	-$6.662M	-$2.830M	-$6.422M
Capital Expenditures	$36.00K	$79.00K	-$12.00K
Free Cash Flow	-$6.698M	-$2.909M	-$6.410M
YoY Change	4.49%	-13.4%	203.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-108.90
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-288.97
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001427570
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	218522
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	371031
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78763
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91080
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84921
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341768
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	172288
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	519219
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	356641
CY2021Q4	us-gaap	Common Stock Value CommonStockValue
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-288.97
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-61.88
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-42.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-103.19
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-50.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-150.31
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-21.87
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-46.37
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-27.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-73.79
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.02
CY2021Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.333
CY2021	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#GoodwillAndIntangibleAssetImpairment
CY2021	rsls	Warrants Reverse Stock Split Ratio WarrantsReverseStockSplitRatio	0.333
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities	0
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	1-37897
CY2022	dei	Entity Registrant Name EntityRegistrantName	RESHAPE LIFESCIENCES INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1828101
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1001 Calle Amanecer
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92673
CY2022	dei	City Area Code CityAreaCode	949
CY2022	dei	Local Phone Number LocalPhoneNumber	429-6680
CY2022	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	RSLS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	10658000
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2649043
CY2022	dei	Auditor Firm AuditorFirmId	49
CY2022	dei	Auditor Name AuditorName	RSM US LLP
CY2022	dei	Auditor Location AuditorLocation	Irvine, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3855000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22765000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	100000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	50000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	410000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1172000
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2180000
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2815000
CY2022Q4	us-gaap	Inventory Net InventoryNet	3611000
CY2021Q4	us-gaap	Inventory Net InventoryNet	3003000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	165000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1305000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9911000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	29938000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	698000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1454000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	171000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	266000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	56000
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	260000
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	20827000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2022Q4	us-gaap	Assets Assets	11142000
CY2021Q4	us-gaap	Assets Assets	52531000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1926000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3468000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5040000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3368000
CY2022Q4	rsls	Warrant Liability Current WarrantLiabilityCurrent	344000
CY2021Q4	rsls	Warrant Liability Current WarrantLiabilityCurrent	415000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	171000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	279000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7481000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7530000
CY2021Q4	rsls	Warrant Liability Non Current WarrantLiabilityNonCurrent	300000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	367000
CY2022Q4	us-gaap	Liabilities Liabilities	7481000
CY2021Q4	us-gaap	Liabilities Liabilities	8197000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	519219
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	356641
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	627935000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	622399000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-624187000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-577973000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-88000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-92000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3661000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44334000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11142000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52531000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11240000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13600000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4438000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5252000
CY2022	us-gaap	Gross Profit GrossProfit	6802000
CY2021	us-gaap	Gross Profit GrossProfit	8348000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14093000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8893000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17250000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24319000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2537000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2369000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	18744000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	30649000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-529000
CY2022	us-gaap	Operating Expenses OperatingExpenses	53153000
CY2021	us-gaap	Operating Expenses OperatingExpenses	66230000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-46351000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-57882000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-113000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-832000
CY2021	rsls	Warrant Expense WarrantExpense	2813000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2061000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-141000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	168000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46594000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63420000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-380000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-274000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46214000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-63146000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-108.90
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-288.97
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	424390
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	424390
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218522
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	218522
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-46214000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-63146000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	29000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	29000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-46210000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63117000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	14488000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-63146000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	29000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	30561000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12227000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	416000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	4508000
CY2021	rsls	Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants	44645000
CY2021	rsls	Adjustments To Additional Paid In Capital Warrant Liability Reclassified To Equity AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityReclassifiedToEquity	476000
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	130000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44334000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-46214000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2087000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	639000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	318000
CY2022	rsls	Stock And Warrants Issued During Period Value Institutional Exercise Of Warrants StockAndWarrantsIssuedDuringPeriodValueInstitutionalExerciseOfWarrants	2493000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3661000
CY2022	us-gaap	Profit Loss ProfitLoss	-46214000
CY2021	us-gaap	Profit Loss ProfitLoss	-63146000
CY2022	us-gaap	Depreciation Depreciation	330000
CY2021	us-gaap	Depreciation Depreciation	232000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1823000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1739000
CY2021	rsls	Noncash Interest Expense NoncashInterestExpense	133000
CY2022	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	18744000
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	30649000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2061000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-529000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2087000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	12227000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-43000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	89000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	579000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	294000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-423000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-248000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2813000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	494000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	23000
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-678000
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	284000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1187000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	369000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1141000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	76000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	448000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1280000
CY2022	rsls	Increase Decrease In Warrant Liability IncreaseDecreaseInWarrantLiability	-371000
CY2021	rsls	Increase Decrease In Warrant Liability IncreaseDecreaseInWarrantLiability	-703000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21902000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15375000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	131000
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	352000
CY2021	rsls	Payments For Asset Acquisition Including Transaction Cost PaymentsForAssetAcquisitionIncludingTransactionCost	3000000
CY2021	rsls	Proceeds Received From Acquisition ProceedsReceivedFromAcquisition	5207000
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	39000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-92000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1855000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3234000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	639000
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2491000
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	45616000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	417000
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1000000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10500000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3130000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33299000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18860000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19808000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22815000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3007000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3955000
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1069000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22815000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	102000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	296000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25355000
CY2021	rsls	Fair Value Of Warrants Included In Loss On Extinguishment Of Debt FairValueOfWarrantsIncludedInLossOnExtinguishmentOfDebt	2974000
CY2021	rsls	Fair Value Of Common Stock And Warrants Related To Fundamental Transaction Exchange FairValueOfCommonStockAndWarrantsRelatedToFundamentalTransactionExchange	2813000
CY2021	us-gaap	Stock Issued1 StockIssued1	97000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1305000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	29938000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2021Q4	us-gaap	Assets Assets	52531000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3368000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7530000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	367000
CY2021Q4	us-gaap	Liabilities Liabilities	8197000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	622399000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-577973000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44334000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52531000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8893000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24319000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2369000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	30649000
CY2021	us-gaap	Operating Expenses OperatingExpenses	66230000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-57882000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63420000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-274000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-63146000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-288.97
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218522
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-63146000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63117000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	14488000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-63146000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12227000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44334000
CY2021	us-gaap	Profit Loss ProfitLoss	-63146000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	30649000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	12227000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-248000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	76000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1280000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	65303000
CY2021Q2	us-gaap	Goodwill Goodwill	23520000
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2021Q2	us-gaap	Assets Assets	120013000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-523590000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	58132000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120013000
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1317000
CY2021Q3	us-gaap	Assets Current AssetsCurrent	37273000
CY2021Q3	us-gaap	Goodwill Goodwill	22950000
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2021Q3	us-gaap	Assets Assets	90790000
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	620125000
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-540724000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	79312000
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90790000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-61.88
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78763
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4298000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7018000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	5842000
	us-gaap	Operating Expenses OperatingExpenses	10383000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3689000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5947000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3861000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8710000
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3889000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8763000
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-42.70
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-103.19
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91080
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84921
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3246000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5937000
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11883000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18902000
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1425000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2099000
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	16554000
	us-gaap	Operating Expenses OperatingExpenses	26938000
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14419000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20366000
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17164000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25874000
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17134000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25897000
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-50.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-150.31
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	341768
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	172288
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3889000
	us-gaap	Net Income Loss NetIncomeLoss	-8763000
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3896000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8751000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-17134000
	us-gaap	Net Income Loss NetIncomeLoss	-25897000
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17132000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25883000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	12708000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3889000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	58132000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	14488000
	us-gaap	Net Income Loss NetIncomeLoss	-8763000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	58132000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	58132000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-17134000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10234000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	79312000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	14488000
	us-gaap	Net Income Loss NetIncomeLoss	-25897000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9971000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	79312000
	us-gaap	Profit Loss ProfitLoss	-8763000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-36000
	us-gaap	Profit Loss ProfitLoss	-25897000
	us-gaap	Share Based Compensation ShareBasedCompensation	9971000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	83000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1443000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	23311000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2022Q1	us-gaap	Assets Assets	45623000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3482000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8170000
CY2022Q1	us-gaap	Liabilities Liabilities	8664000
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	623118000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-586088000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	36959000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45623000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	953000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	19171000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2022Q2	us-gaap	Assets Assets	40357000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5833000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9209000
CY2022Q2	us-gaap	Liabilities Liabilities	9581000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	626380000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-595532000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	30776000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40357000
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	610000
CY2022Q3	us-gaap	Assets Current AssetsCurrent	13257000
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	12031000
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46000
CY2022Q3	us-gaap	Assets Assets	26485000
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4867000
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7532000
CY2022Q3	us-gaap	Liabilities Liabilities	7532000
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	626739000
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-607718000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	18953000
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26485000
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4694000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3892000
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	745000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	9331000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8113000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8085000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8115000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-21.87
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	371031
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4636000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9330000
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5363000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9254000
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	747000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1492000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	11127000
	us-gaap	Operating Expenses OperatingExpenses	20457000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9244000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17356000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9435000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17520000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9444000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17559000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-46.37
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2605000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11936000
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3784000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13037000
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	583000
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-17559000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2075000
CY2022Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	7429000
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	7429000
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	14402000
	us-gaap	Operating Expenses OperatingExpenses	34860000
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12301000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29658000
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12549000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30069000
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-363000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-324000
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12186000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29745000
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-27.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-73.79
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-8115000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8094000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9444000
	us-gaap	Net Income Loss NetIncomeLoss	-17559000
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9445000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17539000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12186000
	us-gaap	Net Income Loss NetIncomeLoss	-29745000
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12182000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29721000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44334000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-8115000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	719000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	36959000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	36959000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9444000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	770000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	30776000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44334000
	us-gaap	Net Income Loss NetIncomeLoss	-17559000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1489000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	30776000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	30776000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12186000
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	359000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	18953000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	44334000
	us-gaap	Net Income Loss NetIncomeLoss	-29745000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1848000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	18953000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-8115000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	719000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	240000
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1489000
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1500000
	us-gaap	Profit Loss ProfitLoss	-29745000
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	7429000
	us-gaap	Share Based Compensation ShareBasedCompensation	1848000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-368000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-51000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 12.25pt;"><i style="font-style:italic;">Use of Estimates </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:27pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. </p>
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	100000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	50000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3855000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22765000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	100000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	50000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3955000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22815000
CY2022	rsls	Number Of Customers NumberOfCustomers	1
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	100000
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	1000000.0
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	800000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	832000
CY2022	rsls	Restocking Fee RestockingFee	0.10
CY2022	rsls	Standard Product Warranty Term StandardProductWarrantyTerm	P30D
CY2022	us-gaap	Advertising Expense AdvertisingExpense	6800000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	3000000.0
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 12.25pt;"><i style="font-style:italic;">Concentration of Credit Risk, Interest Rate Risk and Foreign Currency Exchange Rate </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:24.5pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash and trade accounts receivable. Cash and cash equivalents are primarily deposited in demand and money market accounts. At times, such deposits may be in excess of insured limits. Investments in money market funds are not considered to be bank deposits and are not insured or guaranteed by the federal deposit insurance company or other government agency. These money market funds seek to preserve the value of the investment at $1.00 per share; however, it is possible to lose money investing in these funds. The Company has not experienced any losses on its deposits of cash and cash equivalents. To minimize the risk associated with trade accounts receivable, management maintains relationships with the Company’s customers that allow management to monitor current changes in business operations so the Company can respond as needed. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:24.5pt;margin:0pt 0pt 12pt 0pt;">Substantially all of the Company’s revenue is denominated in U.S. dollars. Only a small portion of revenue and expenses are denominated in foreign currencies, principally the Australian dollar and Euro for 2022 and 2021. The Company has not entered into any hedging contracts. Future fluctuations in the value of the U.S. dollar may affect the price competitiveness of the Company’s products outside the U.S.</p>
CY2022Q4	rsls	Working Capital WorkingCapital	2400000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4000000.0
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4000000.0
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2200000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-624200000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	829000
CY2022Q4	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	864000
CY2021Q4	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	682000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1915000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1492000
CY2022Q4	us-gaap	Inventory Net InventoryNet	3611000
CY2021Q4	us-gaap	Inventory Net InventoryNet	3003000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	78000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	419000
CY2022Q4	rsls	Prepaid Advertising And Marketing Expenses PrepaidAdvertisingAndMarketingExpenses	3000
CY2021Q4	rsls	Prepaid Advertising And Marketing Expenses PrepaidAdvertisingAndMarketingExpenses	698000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	84000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	188000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	165000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1305000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1829000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1527000
CY2022Q4	rsls	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	1775000
CY2021Q4	rsls	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	180000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	510000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	549000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	119000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	326000
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	301000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	316000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	300000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	491000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	185000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5040000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3368000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1029000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1794000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	331000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	340000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	698000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1454000
CY2022	us-gaap	Depreciation Depreciation	330000
CY2021	us-gaap	Depreciation Depreciation	232000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6451000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6191000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	260000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19213000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5333000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13880000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	26160000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5333000
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	20827000
CY2022Q4	rsls	Indefinite Lived Intangible Assets Excluding Goodwill Before Impairment IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment	20721000
CY2021Q4	rsls	Indefinite Lived Intangible Assets Excluding Goodwill Before Impairment IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeImpairment	20721000
CY2022Q4	rsls	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	20721000
CY2021Q4	rsls	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	13774000
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	6947000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1700000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	44000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	44000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	44000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	44000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	44000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	40000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	260000
CY2022	rsls	Intangible Assets Fair Value Discount Rate IntangibleAssetsFairValueDiscountRate	0.179
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7200000
CY2021	rsls	Intangible Assets Fair Value Discount Rate IntangibleAssetsFairValueDiscountRate	0.217
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	23500000
CY2021	rsls	Employee Retention Credit Cares Act EmployeeRetentionCreditCaresAct	500000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	700000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	600000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	171000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	266000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	171000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	279000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	171000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	279000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	560000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	565000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	174000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	174000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	171000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.051
CY2021Q2	rsls	Warrant Liability WarrantLiability	2000000.0
CY2021Q3	rsls	Warrant Liability WarrantLiability	1300000
CY2021Q3	rsls	Increase Decrease In Warrant Liability IncreaseDecreaseInWarrantLiability	-700000
CY2021Q3	rsls	Warrants Number Of Holders Exercised Fundamental Transaction Option WarrantsNumberOfHoldersExercisedFundamentalTransactionOption	1
CY2021Q3	rsls	Class Of Warrant Or Right Fair Value Disclosure ClassOfWarrantOrRightFairValueDisclosure	900000
CY2021Q3	rsls	Warrants Reclassified To Equity WarrantsReclassifiedToEquity	500000
CY2021	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	13432000
CY2021	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	-71178000
CY2021Q3	rsls	Class Of Warrant Or Right Exercise Price As Percentage Of Common Stock Price ClassOfWarrantOrRightExercisePriceAsPercentageOfCommonStockPrice	0.95
CY2021Q2	rsls	Class Of Warrant Or Right New Warrants As Percentage Of Common Stock Issued For Warrants Exercised ClassOfWarrantOrRightNewWarrantsAsPercentageOfCommonStockIssuedForWarrantsExercised	0.75
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4000
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3754
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1454
CY2021Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	200000
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	364
CY2021Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	42000
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1838
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	200000
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	161050
CY2021	rsls	Warrants Obtained Due To Merger WarrantsObtainedDueToMerger	17505
CY2021	rsls	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	138215
CY2021	rsls	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	177723
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	139047
CY2022	rsls	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	145192
CY2022	rsls	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	84614
CY2022	rsls	Class Of Warrant Or Right Cancelled In Period ClassOfWarrantOrRightCancelledInPeriod	6149
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	193476
CY2021Q3	rsls	Warrants Converted WarrantsConverted	10098
CY2021	rsls	Warrants Converted WarrantsConverted	10098
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11240000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13600000
CY2022Q4	rsls	Number Of Products In Development Stage NumberOfProductsInDevelopmentStage	2
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.033
CY2021	rsls	Effectiveincometaxratereconciliationdeductionsstockwarrantvaluation Effectiveincometaxratereconciliationdeductionsstockwarrantvaluation	-0.020
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.078
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.120
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.019
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2087000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12227000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-293000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-218000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-76000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-30000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-54000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-423000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-248000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	30000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	4000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-37000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-380000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-274000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.038
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.038
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.002
CY2021	rsls	Effective Income Tax Rate Reconciliation Net Operating Loss Adjustment Percent EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent	-0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.028
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.250
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.021
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.008
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.004
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1052000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1052000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1052000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1052000
CY2022Q4	rsls	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	1137000
CY2021Q4	rsls	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	1225000
CY2022Q4	rsls	Deferred Tax Assets Capitalized Research And Development Costs DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts	272000
CY2021Q4	rsls	Deferred Tax Assets Capitalized Research And Development Costs DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts	408000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	1157000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	1679000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	4597000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2492000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2492000
CY2022Q4	rsls	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	43000
CY2021Q4	rsls	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	74000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	63424000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	55725000
CY2022Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	2000
CY2021Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	2000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	73124000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	61605000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	72945000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	61231000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	179000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	374000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	80000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	23000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	648000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	43000
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	70000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	123000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	741000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	56000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	367000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	82500000
CY2021Q4	rsls	Research And Development Credits Operating Loss Carryforwards ResearchAndDevelopmentCreditsOperatingLossCarryforwards	3400000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	rsls	Severance Benefits Payable SeveranceBenefitsPayable	800000
CY2022Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	2900000

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
rsls-20221231x10k_htm.xml	Edgar Link	completed
0001558370-23-006079-index-headers.html	Edgar Link	pending
0001558370-23-006079-index.html	Edgar Link	pending
0001558370-23-006079.txt	Edgar Link	pending
0001558370-23-006079-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rsls-20221231.xsd	Edgar Link	pending
rsls-20221231x10k.htm	Edgar Link	pending
rsls-20221231x10k003.jpg	Edgar Link	pending
rsls-20221231x10k004.jpg	Edgar Link	pending
rsls-20221231x10k005.jpg	Edgar Link	pending
rsls-20221231xex10d6.htm	Edgar Link	pending
rsls-20221231xex10d8.htm	Edgar Link	pending
rsls-20221231xex10d8g001.jpg	Edgar Link	pending
rsls-20221231xex10d8g002.jpg	Edgar Link	pending
rsls-20221231xex10d8g003.jpg	Edgar Link	pending
rsls-20221231xex10d8g004.jpg	Edgar Link	pending
rsls-20221231xex10d8g005.jpg	Edgar Link	pending
rsls-20221231xex10d8g006.jpg	Edgar Link	pending
rsls-20221231xex10d8g007.jpg	Edgar Link	pending
rsls-20221231xex10d8g008.jpg	Edgar Link	pending
rsls-20221231xex10d8g009.jpg	Edgar Link	pending
rsls-20221231xex10d8g010.jpg	Edgar Link	pending
rsls-20221231xex10d8g011.jpg	Edgar Link	pending
rsls-20221231xex10d8g012.jpg	Edgar Link	pending
rsls-20221231xex10d8g013.jpg	Edgar Link	pending
rsls-20221231xex10d8g014.jpg	Edgar Link	pending
rsls-20221231xex10d8g015.jpg	Edgar Link	pending
rsls-20221231xex10d8g016.jpg	Edgar Link	pending
rsls-20221231xex10d8g017.jpg	Edgar Link	pending
rsls-20221231xex10d8g018.jpg	Edgar Link	pending
rsls-20221231xex10d8g019.jpg	Edgar Link	pending
rsls-20221231xex10d8g020.jpg	Edgar Link	pending
rsls-20221231xex10d8g021.jpg	Edgar Link	pending
rsls-20221231xex10d8g022.jpg	Edgar Link	pending
rsls-20221231xex10d8g023.jpg	Edgar Link	pending
rsls-20221231xex10d8g024.jpg	Edgar Link	pending
rsls-20221231xex21d1.htm	Edgar Link	pending
rsls-20221231xex23d1.htm	Edgar Link	pending
rsls-20221231xex23d2.htm	Edgar Link	pending
rsls-20221231xex31d1.htm	Edgar Link	pending
rsls-20221231xex31d2.htm	Edgar Link	pending
rsls-20221231xex32d1.htm	Edgar Link	pending
rsls-20221231xex32d2.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rsls-20221231_cal.xml	Edgar Link	unprocessable
rsls-20221231_def.xml	Edgar Link	unprocessable
rsls-20221231_lab.xml	Edgar Link	unprocessable
rsls-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RSLS
ReShape Lifesciences Inc. Stock $rsls

2023 Q2 Form 10-K Financial Statement

#000155837023006079 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RSLS ReShape Lifesciences Inc. Stock $rsls

2023 Q2 Form 10-K Financial Statement

#000155837023006079 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RSLS
ReShape Lifesciences Inc. Stock $rsls